|
Name |
Isochromophilone VIII
|
Molecular Formula | C21H27ClO5 | |
IUPAC Name* |
[5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1H-isochromen-8-yl] acetate
|
|
SMILES |
CCC(C)/C=C(\C)/C=C/C1=CC2=C(C(=O)C(C(C2CO1)OC(=O)C)(C)O)Cl
|
|
InChI |
InChI=1S/C21H27ClO5/c1-6-12(2)9-13(3)7-8-15-10-16-17(11-26-15)20(27-14(4)23)21(5,25)19(24)18(16)22/h7-10,12,17,20,25H,6,11H2,1-5H3/b8-7+,13-9+
|
|
InChIKey |
MMOJJYPBNVVCGY-NJHPPEEMSA-N
|
|
Synonyms |
Isochromophilone VIII; 175773-90-7; [5-chloro-3-[(1E,3E)-3,5-dimethylhepta-1,3-dienyl]-7-hydroxy-7-methyl-6-oxo-8,8a-dihydro-1H-isochromen-8-yl] acetate; FO-4164 VIII; 6H-2-Benzopyran-6-one, 8-(acetyloxy)-5-chloro-3-(3,5-dimethyl-1,3-heptadienyl)-1,7,8,8a-tetrahydro-7-hydroxy-7-methyl-
|
|
CAS | 175773-90-7 | |
PubChem CID | 6443572 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 394.9 | ALogp: | 4.1 |
HBD: | 1 | HBA: | 5 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 72.8 | Aromatic Rings: | 2 |
Heavy Atoms: | 27 | QED Weighted: | 0.549 |
Caco-2 Permeability: | -4.587 | MDCK Permeability: | 0.00001470 |
Pgp-inhibitor: | 0.023 | Pgp-substrate: | 0.371 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.031 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.873 | Plasma Protein Binding (PPB): | 95.56% |
Volume Distribution (VD): | 2.682 | Fu: | 5.84% |
CYP1A2-inhibitor: | 0.107 | CYP1A2-substrate: | 0.116 |
CYP2C19-inhibitor: | 0.215 | CYP2C19-substrate: | 0.847 |
CYP2C9-inhibitor: | 0.192 | CYP2C9-substrate: | 0.098 |
CYP2D6-inhibitor: | 0.209 | CYP2D6-substrate: | 0.12 |
CYP3A4-inhibitor: | 0.877 | CYP3A4-substrate: | 0.722 |
Clearance (CL): | 6.328 | Half-life (T1/2): | 0.394 |
hERG Blockers: | 0.001 | Human Hepatotoxicity (H-HT): | 0.091 |
Drug-inuced Liver Injury (DILI): | 0.973 | AMES Toxicity: | 0.555 |
Rat Oral Acute Toxicity: | 0.852 | Maximum Recommended Daily Dose: | 0.952 |
Skin Sensitization: | 0.85 | Carcinogencity: | 0.455 |
Eye Corrosion: | 0.323 | Eye Irritation: | 0.709 |
Respiratory Toxicity: | 0.974 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001877 | 1.000 | D05QDC | 0.225 | ||||
ENC001875 | 0.744 | D0G3PI | 0.224 | ||||
ENC005596 | 0.742 | D00DKK | 0.224 | ||||
ENC005595 | 0.729 | D02DGU | 0.224 | ||||
ENC005431 | 0.616 | D0B1IP | 0.224 | ||||
ENC005432 | 0.586 | D0S7WX | 0.217 | ||||
ENC001884 | 0.558 | D0E9KA | 0.213 | ||||
ENC002178 | 0.548 | D02CNR | 0.211 | ||||
ENC001876 | 0.511 | D0H2MO | 0.210 | ||||
ENC001841 | 0.500 | D0V2JK | 0.207 |